Snowball logo
logo
BSLN_logo

Basilea Pharmaceutica AG

BSLN β€’ SW
Fr53.00+Fr0.40Β  (0.76%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
148.1147.8157.6208.5232.4389
COGS
24.0726.826.7938.6839.385.01
Gross Profit
124121130.8169.9193.1303.9
Operating Expenses & Income
Operating Income
1.18718.5419.261.1851.6100.8
Total Operating Expenses
122.9104.6111.6108.7141.5203.2
R&D Expenses
93.1673.877.8577.14105.9163.9
Selling General & Admin Expenses
29.7230.8233.7831.5435.6267.16
Earnings from Continuing Operations
Interest Expense
(8.151)(9.848)(11.2)(4.344)(3.357)(7.701)
Interest Income
8.0850.3261.691.4162.0875.015
Income Tax Expense
0.037(0.045)0.01(17.33)5.6(13.5)
Net Income
Net Income
(6.831)12.1510.4577.5940.2109.9
Supplemental
EBIT
4.26923.1121.6161.751.55101.4
EBITDA
6.72326.2123.1863.1355.26105
In millions of CHF, except % and values per 1 share